For African Americans, diabetes is a serious health concern, affecting 12.7% of the population. Most people recognize the complications of diabetes, such as heart disease, stroke, neuropathy, and eye problems, but did you know that people with diabetes are at an increased risk of breaking a bone? In 2017, Jennifer Walsh published an article looking at type 2 diabetes and bone in adults. 
People with Type 2 diabetes typically have higher bone density, due to increased body weight, so they may not get diagnosed with osteoporosis or low bone density that would trigger steps to prevent fractures and reduce the chance of fractures. However, there is a 1–2 times greater chance of fractures for people with diabetes.
What accounts for this increase in risk of fracture is still being studied, but there is emerging evidence that the excess sugar in the bloodstream attaches to the collagen the bone. The reason this is important is that the collagen in the bone makes the bone tougher and less likely to break when it has a force put on it, like a fall. When the sugar attaches to the collagen, it creates structural changes that make the bone less flexible and more brittle.,
Researchers who have looked at the properties of bone in people with type 2 diabetes have found that the strength of the bone in these patients is 10% less than is patients without type 2 diabetes.
There is also some evidence that treatments for diabetes, such as Metformin, can reduce the risk of fracture, while others like TZDs and glitazones, actually increase the risk of fracture.
The bottom line is that people with type 2 diabetes need to be concerned about their bone health. Steps to take: 1) work to control blood sugar, 2) improve strength and balance to prevent falls, and 3) talk to a health care provider about fracture risk and whether you should take a medication to reduce your fracture risk.
 Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017.
 Walsh, J.S. & Vilaca, T. Calcif Tissue Int (2017) 100: 528. https://doi.org/10.1007/s00223-016-0229-0
 Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporosis Int 18(4):427–444. doi: 10.1007/s00198-006-0253-4
 Saito M, Fujii K, Mori Y, Marumo K (2006) Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17(10):1514–1523. doi: 10.1007/s00198-006-0155-5
 Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G, Diabetes Outcome Progression Trial Study Group (2008) Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT). Diabetes Care 31(5):845–851. doi: 10.2337/dc07-2270